CMR Surgical was last valued at $3B (post-money). It comes from the $131M Series D of Apr 2025. The company is private, so there is no listed share price.
2 valuations. The latest, $3B post-money, was set by the Series D in Apr 2025.
A private valuation is the price agreed in one transaction. The CMR Surgical valuation of $3B is a post-money figure from the Series D dated 2 Apr 2025 — the whole company measured after the $131M raised in that round was already inside it. Subtract the round and the pre-money view of the same deal is $2.9B .
The valuation holds until the next priced round or secondary sale. A private company founded in 2014 with roughly 650 people has no daily price and no order book between rounds.
The last valuation is $3B (post-money, Apr 2025).
Lead investors for each round are in the funding timeline.
The closest medical devices & equipment (surgical robotics) peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. CMR Surgical is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
